Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smartphone app ease mysterious body aches? new study says maybe.

NCT ID NCT07296406

Symptom relief Sponsor: Gangnam Severance Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a mobile app could help adults with somatic symptom disorder or medically unexplained symptoms. 46 participants used the app for 8 weeks, which taught coping skills like mindfulness and stress management. The goal was to see if symptoms improved compared to usual care alone.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
mobile self-management application with psychoeducation, CBT, mindfulness, stress management, and behavioral monitoring
What this could lead to
If it works, this could provide a scalable, accessible tool to help people manage persistent physical symptoms that have no clear medical cause.
What could go wrong
This is a small pilot study with only 46 participants, so results may not apply broadly. The app is an add-on to usual care, and its benefits may be modest or not last long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

46 people

The number who actually took part.

Started

Jul 2024

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 19 years or older * PHQ-15 score of 4 or higher * Presence of medically unexplained physical symptoms (MUS) * No significant impairment in reading or writing ability * Familiarity with smartphone and internet use Exclusion Criteria: * Current diagnosis of substance use disorder (alcohol or drugs) * Current diagnosis of schizophrenia or bipolar disorder, or presence of psychiatric symptoms deemed by the clinician to interfere with participation * Currently receiving psychotherapy specifically for somatic symptoms * Diagnosis of developmental disorders such as autism or intellectual disability, or evidence of significant cognitive impairment * Any other medical condition deemed by the clinician to make participation inappropriate * Inability to continue participation due to smartphone malfunction or lack of sufficient smartphone skills

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Somatic symptom disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

somatization disorder somatoform disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Somatic symptom disorder

Contacts and locations

Locations

  • Gangnam Severance Hospital

    Seoul, 06273, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.